Faes Farma SA (MC:FAE) — Stock Price
Faes Farma SA (MC:FAE) is currently trading at €4.52 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €4.13 and €5.38. This page tracks Faes Farma SA's live share price on the MC exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see FAE stock market capitalisation.
Faes Farma SA (FAE) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Faes Farma SA's daily closing share price and trading volume on the MC exchange over the past year, giving a clear view of recent price momentum and liquidity.
Faes Farma SA Income Statement — Revenue, Profit & Earnings by Year
Faes Farma SA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €610.46 Million | €493.65 Million | €451.17 Million | €438.75 Million | €398.56 Million |
| Cost of Revenue | €382.00 Million | €167.11 Million | €154.05 Million | €156.74 Million | €146.16 Million |
| Gross Profit | €228.46 Million | €326.54 Million | €297.12 Million | €282.01 Million | €252.40 Million |
| Research & Development | €4.89 Million | €5.80 Million | €5.20 Million | €3.72 Million | €3.89 Million |
| SG&A | — | €106.02 Million | €33.24 Million | €28.89 Million | €27.93 Million |
| Total Operating Expenses | €155.70 Million | €219.45 Million | €99.95 Million | €179.59 Million | €153.53 Million |
| Operating Income | €72.76 Million | €107.08 Million | €81.22 Million | €79.35 Million | €67.43 Million |
| EBITDA | €101.80 Million | €128.33 Million | €122.93 Million | €121.35 Million | €110.84 Million |
| EBIT | €72.76 Million | €108.01 Million | €103.54 Million | €102.08 Million | €93.58 Million |
| Interest Expense | €6.32 Million | €433.00K | €684.00K | €660.00K | €615.00K |
| Income Before Tax | €85.41 Million | €107.58 Million | €102.85 Million | €101.42 Million | €92.97 Million |
| Income Tax Expense | €5.75 Million | €-3.54 Million | €11.16 Million | €11.92 Million | €10.52 Million |
| Net Income | €79.63 Million | €111.36 Million | €91.90 Million | €89.50 Million | €82.39 Million |
Faes Farma SA Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Faes Farma SA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €1.34 Billion | €853.08 Million | €776.03 Million | €725.67 Million | €641.76 Million |
| Total Current Assets | €482.40 Million | €333.73 Million | €290.29 Million | €313.21 Million | €293.71 Million |
| Cash & Equivalents | — | — | — | €66.41 Million | €70.25 Million |
| Short-term Investments | €12.78 Million | €7.92 Million | €13.10 Million | €17.69 Million | €3.15 Million |
| Net Receivables | €167.30 Million | €119.06 Million | €103.03 Million | €114.11 Million | €112.85 Million |
| Inventory | €185.01 Million | €142.52 Million | €129.03 Million | €113.99 Million | €106.48 Million |
| Property, Plant & Equipment | — | — | — | €205.80 Million | €117.78 Million |
| Goodwill | €258.48 Million | €56.51 Million | €56.08 Million | €51.78 Million | €65.72 Million |
| Total Liabilities | €594.19 Million | €126.46 Million | €112.68 Million | €123.39 Million | €103.70 Million |
| Total Current Liabilities | €184.88 Million | €103.45 Million | €86.82 Million | €94.43 Million | €79.31 Million |
| Long-term Debt | €373.73 Million | €0.00 | €0.00 | €3.00K | €3.50 Million |
| Net Debt | €292.60 Million | €-56.43 Million | €-10.75 Million | €-33.73 Million | €-53.81 Million |
| Total Stockholder Equity | €744.80 Million | €725.87 Million | €662.36 Million | €601.08 Million | €536.53 Million |
| Retained Earnings | €181.83 Million | €196.28 Million | €640.95 Million | €136.16 Million | €127.78 Million |
Faes Farma SA Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Faes Farma SA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €78.49 Million | €115.47 Million | €100.97 Million | €106.79 Million | €79.64 Million |
| Capital Expenditures | €16.11 Million | €39.52 Million | €102.19 Million | €80.95 Million | €59.42 Million |
| Free Cash Flow | €62.38 Million | €75.95 Million | €-1.22 Million | €25.84 Million | €20.23 Million |
| Investing Cash Flow | €-299.02 Million | €-34.18 Million | €-97.36 Million | €-92.17 Million | €-83.48 Million |
| Financing Cash Flow | €273.62 Million | €-51.71 Million | €-35.38 Million | €-18.46 Million | €-17.12 Million |
| Dividends Paid | €-55.72 Million | €-48.24 Million | €-14.61 Million | €18.15 Million | €13.72 Million |
| Stock-Based Compensation | — | €747.00K | €774.00K | €146.00K | €-3.39 Million |
| Depreciation | €29.03 Million | €20.32 Million | €19.40 Million | €19.27 Million | €16.23 Million |
| Change in Cash | €53.09 Million | €29.57 Million | €-31.76 Million | €-3.84 Million | €-20.96 Million |
Faes Farma SA Earnings History — EPS Actual vs. Analyst Estimates
Track Faes Farma SA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jul 23, 2026 | — | — | — |
| Apr 30, 2026 | — | — | — |
| Feb 26, 2026 | — | — | — |
| Nov 07, 2025 | — | — | — |
| Feb 25, 2025 | — | — | — |
| Oct 31, 2024 | — | — | — |
| Oct 24, 2019 | 0.06 | — | — |
| Jul 24, 2019 | 0.07 | — | — |